A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc.
Verismo Therapeutics
Nurix Therapeutics, Inc.
Newave Pharmaceutical Inc
Schrödinger, Inc.
Carna Biosciences, Inc.
Mayo Clinic
Accutar Biotechnology Inc
Stanford University